310 related articles for article (PubMed ID: 30838648)
1. Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladder.
Isharwal S; Hu W; Sarungbam J; Chen YB; Gopalan A; Fine SW; Tickoo SK; Sirintrapun SJ; Jadallah S; Loo FL; Pietzak EJ; Cha EK; Bochner BH; Berger MF; Iyer G; Solit DB; Reuter VE; Al-Ahmadie H
J Pathol; 2019 Jul; 248(3):260-265. PubMed ID: 30838648
[TBL] [Abstract][Full Text] [Related]
2. RAS Family Gene Mutations, Clinicopathological Features, and Spread Patterns of Inverted Urothelial Papilloma of the Bladder.
Kitahama K; Shigematsu Y; Amori G; Sugawara E; Yonese J; Shibahara J; Takeuchi K; Inamura K
Am J Surg Pathol; 2024 Apr; 48(4):458-464. PubMed ID: 38145408
[TBL] [Abstract][Full Text] [Related]
3. Biological significance of TERT promoter mutation in papillary urothelial neoplasm of low malignant potential.
Wang CC; Huang CY; Jhuang YL; Chen CC; Jeng YM
Histopathology; 2018 Apr; 72(5):795-803. PubMed ID: 29193225
[TBL] [Abstract][Full Text] [Related]
4. HRAS mutations are frequent in inverted urothelial neoplasms.
McDaniel AS; Zhai Y; Cho KR; Dhanasekaran SM; Montgomery JS; Palapattu G; Siddiqui J; Morgan T; Alva A; Weizer A; Lee CT; Chinnaiyan AM; Quist MJ; Grasso CS; Tomlins SA; Mehra R
Hum Pathol; 2014 Sep; 45(9):1957-65. PubMed ID: 25097040
[TBL] [Abstract][Full Text] [Related]
5. Telomerase reverse transcriptase (TERT) promoter mutation analysis of benign, malignant and reactive urothelial lesions reveals a subpopulation of inverted papilloma with immortalizing genetic change.
Cheng L; Davidson DD; Wang M; Lopez-Beltran A; Montironi R; Wang L; Tan PH; MacLennan GT; Williamson SR; Zhang S
Histopathology; 2016 Jul; 69(1):107-13. PubMed ID: 26679899
[TBL] [Abstract][Full Text] [Related]
6. Distinct mutational landscape of inverted urothelial papilloma.
Akgul M; MacLennan GT; Cheng L
J Pathol; 2019 Sep; 249(1):3-5. PubMed ID: 31119740
[TBL] [Abstract][Full Text] [Related]
7. Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma.
Eich ML; Rodriguez Pena MDC; Springer SU; Taheri D; Tregnago AC; Salles DC; Bezerra SM; Cunha IW; Fujita K; Ertoy D; Bivalacqua TJ; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Netto GJ
Mod Pathol; 2019 Oct; 32(10):1544-1550. PubMed ID: 31028363
[TBL] [Abstract][Full Text] [Related]
8. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
[TBL] [Abstract][Full Text] [Related]
9. Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications.
Kurtis B; Zhuge J; Ojaimi C; Ye F; Cai D; Zhang D; Fallon JT; Zhong M
Ann Diagn Pathol; 2016 Apr; 21():7-11. PubMed ID: 27040924
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and morphological features of a non-invasive papillary urothelial carcinoma, evolving from a urothelial inverted papilloma of the bladder].
Pascal A; Dobromir N; Ivan L
Rev Med Chir Soc Med Nat Iasi; 2009; 113(1):150-3. PubMed ID: 21495311
[TBL] [Abstract][Full Text] [Related]
11. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
Juanpere N; Agell L; Lorenzo M; de Muga S; López-Vilaró L; Murillo R; Mojal S; Serrano S; Lorente JA; Lloreta J; Hernández S
Hum Pathol; 2012 Oct; 43(10):1573-82. PubMed ID: 22417847
[TBL] [Abstract][Full Text] [Related]
12. [Significance of TERT promoter mutation in differential diagnosis of non-invasive inverted urothelial lesions of bladder].
Zhang YH; Xie JJ; Wang JG; Wang Y; Zhan XH; Gao J; He HY
Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1216-1222. PubMed ID: 38058037
[No Abstract] [Full Text] [Related]
13. Inverted urothelial papilloma: is ploidy, MIB-1 proliferative activity, or p53 protein accumulation predictive of urothelial carcinoma?
Cheville JC; Wu K; Sebo TJ; Cheng L; Riehle D; Lohse CM; Shane V
Cancer; 2000 Feb; 88(3):632-6. PubMed ID: 10649258
[TBL] [Abstract][Full Text] [Related]
14. Inverted Papilloma of the Bladder Coexisting with Urothelial Carcinoma. A Case Report.
Veiga RS; Cassis J; Oliveira P; Lopez-Beltran A
Anal Quant Cytopathol Histpathol; 2016 Feb; 38(1):52-6. PubMed ID: 27363067
[TBL] [Abstract][Full Text] [Related]
15. Inverted papilloma of the bladder: a review and an analysis of the recent literature of 365 patients.
Picozzi S; Casellato S; Bozzini G; Ratti D; Macchi A; Rubino B; Pace G; Carmignani L
Urol Oncol; 2013 Nov; 31(8):1584-90. PubMed ID: 22520573
[TBL] [Abstract][Full Text] [Related]
16. Frequent FGFR3 mutations in urothelial papilloma.
van Rhijn BW; Montironi R; Zwarthoff EC; Jöbsis AC; van der Kwast TH
J Pathol; 2002 Oct; 198(2):245-51. PubMed ID: 12237885
[TBL] [Abstract][Full Text] [Related]
17. Inverted urothelial papilloma of the urinary bladder with focal papillary pattern: a previously undescribed feature.
Albores-Saavedra J; Chable-Montero F; Hernández-Rodríguez OX; Montante-Montes de Oca D; Angeles-Angeles A
Ann Diagn Pathol; 2009 Jun; 13(3):158-61. PubMed ID: 19433293
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.
Nguyen D; Taheri D; Springer S; Cowan M; Guner G; Mendoza Rodriguez MA; Wang Y; Kinde I; VandenBussche CJ; Olson MT; Ricardo BF; Cunha I; Fujita K; Ertoy D; Kinzler KW; Bivalacqua TJ; Papadopoulos N; Vogelstein B; Netto GJ
Virchows Arch; 2016 Oct; 469(4):427-34. PubMed ID: 27520411
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder.
Rodriguez Pena MDC; Tregnago AC; Eich ML; Springer S; Wang Y; Taheri D; Ertoy D; Fujita K; Bezerra SM; Cunha IW; Raspollini MR; Yu L; Bivalacqua TJ; Papadopoulos N; Kinzler KW; Vogelstein B; Netto GJ
Virchows Arch; 2017 Dec; 471(6):761-767. PubMed ID: 28597078
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma.
Moss TJ; Qi Y; Xi L; Peng B; Kim TB; Ezzedine NE; Mosqueda ME; Guo CC; Czerniak BA; Ittmann M; Wheeler DA; Lerner SP; Matin SF
Eur Urol; 2017 Oct; 72(4):641-649. PubMed ID: 28601352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
